The Biotech Growth Trust PLC (the “Company”)
Compliance with Market Abuse Regulation
12 May 2023
The Company confirms that:
a) all inside
information which the Directors and Company may have had has been
notified to a Regulated Information Service (“RIS”);
b) the Company’s
net asset value per share is calculated and announced through a RIS
on a daily basis;
c) the Company
has no reason to believe that there will be any material difference
between the net asset value per share as at close of business on
Friday, 31 March 2023, which was
announced on Monday, 3 April 2023,
and the financial information to be published in the announcement
of its results for the year ended 31 March
2023.
The Company is, therefore, not prohibited from dealing in its
own securities during the closed period, as defined by the UK
Market Abuse Regulation, which will end on the date of the
publication of its results for the year ended 31 March 2023, expected to be on or after
Thursday, 15 June 2023.
-ENDS-
For further information please contact:
Katherine Manson
Frostrow Capital LLP - 0203 709 8734